These terms altered in the Dp16 heart were dramatically rescued by JAKi treatment (Figure 4G), indicating that normalization of IFN signaling effectively reversed abnormal gene expression programs associated with heart malformations in DS in vivo. The gene discussed is IFNA1; the disease is Dravet syndrome.